Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Seiichiro Kurita"'
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 11, Pp 1925-1933 (2022)
ABSTRACT Aims/Introduction To investigate overlooked diabetes in patients with coronavirus disease 2019 (COVID‐19). Materials and Methods In total, 462 COVID‐19 inpatients were included in this retrospective study. The presence of diabetes before
Externí odkaz:
https://doaj.org/article/04dc7242823d426db785e7e26fb3fb07
Autor:
Masashi Tanaka, Hajime Yamakage, Kazuya Muranaka, Tsutomu Yamada, Rika Araki, Atsushi Ogo, Yuka Matoba, Tetsuhiro Watanabe, Miho Saito, Seiichiro Kurita, Kazuya Yonezawa, Tsuyoshi Tanaka, Masahiro Suzuki, Morio Sawamura, Morio Matsumoto, Motonobu Nishimura, Toru Kusakabe, Hiromichi Wada, Koji Hasegawa, Kazuhiko Kotani, Mitsuhiko Noda, Noriko Satoh-Asahara
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
ObjectiveType 2 diabetes is a risk factor for dementia. We investigated whether serum levels of soluble triggering receptor expressed on myeloid cell 2 (sTREM2), a soluble form of the cell surface receptor TREM2, were predictive of cognitive impairme
Externí odkaz:
https://doaj.org/article/66272ae773394653b3a7a9e0922bb101
Autor:
Hiroki Asakura, Masataka Horita, Koutaro Yokote, Yoshiro Maezawa, Makoto Yonezawa, Takehiro Kanamori, Reina Yamamoto, Masaya Koshizaka, Kyota Akasaki, Seiichiro Kurita
Publikováno v:
Endocrine journal. 67(12)
Werner syndrome (WS), a type of progeria, is a hereditary condition caused by a mutation in the WRN gene. A 62-year-old Japanese woman was diagnosed with WS at the age of 32 and has been visiting the hospital for follow-up since the last 30 years. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef1ee4aced186f1307084fb1a3f6b2b4
https://pubmed.ncbi.nlm.nih.gov/32814719
https://pubmed.ncbi.nlm.nih.gov/32814719
Autor:
Yuki Kita, Toshinari Takamura, Hirofumi Misu, Tsuguhito Ota, Seiichiro Kurita, Yumie Takeshita, Masafumi Uno, Naoto Matsuzawa-Nagata, Ken-Ichiro Kato, Hitoshi Ando, Akio Fujimura, Koji Hayashi, Toru Kimura, Yinhua Ni, Toshiki Otoda, Ken-ichi Miyamoto, Yoh Zen, Yasuni Nakanuma, Shuichi Kaneko
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e43056 (2012)
BACKGROUND: Optimal treatment for nonalcoholic steatohepatitis (NASH) has not yet been established, particularly for individuals without diabetes. We examined the effects of metformin, commonly used to treat patients with type 2 diabetes, on liver pa
Externí odkaz:
https://doaj.org/article/f25b8c9239ac4fec918e1cc57c8226c9
Autor:
Hirofumi Misu, Kazuhide Ishikura, Seiichiro Kurita, Yumie Takeshita, Tsuguhito Ota, Yoshiro Saito, Kazuhiko Takahashi, Shuichi Kaneko, Toshinari Takamura
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34952 (2012)
BACKGROUND: We recently identified selenoprotein P (SeP) as a liver-derived secretory protein that causes insulin resistance in the liver and skeletal muscle; however, it is unknown whether and, if so, how SeP acts on adipose tissue. The present stud
Externí odkaz:
https://doaj.org/article/c0d1d6cce1d349b5b873cd2252506ac7
Autor:
Reina Yamamoto, Kyota Akasaki, Masataka Horita, Makoto Yonezawa, Hiroki Asakura, Takehiro Kanamori, Yoshiro Maezawa, Masaya Koshizaka, Koutaro Yokote, Seiichiro Kurita
Publikováno v:
Endocrine Journal; 2020, Vol. 67 Issue 12, p1239-1246, 8p
Autor:
Hirofumi Misu, Kazuhide Ishikura, Hitoshi Ando, Yumie Takeshita, Seiichiro Kurita, Akio Fujimura, Ken-ichiro Kato, Akiko Shimizu, Shuichi Kaneko, Toshinari Takamura, Koumei Taji, Masafumi Uno
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 39(6):528-534
Few studies have evaluated the pharmacokinetics of rapid-acting insulin analogues in patients with Type 2 diabetes, especially under clinical conditions. The aim of the present study was to assess both the pharmacokinetics and pharmacodynamics of ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::886a618a2a8b07b7b3c190b1345ed5da
http://hdl.handle.net/2297/31973
http://hdl.handle.net/2297/31973
Autor:
Toshinari Takamura, Naoto Matsuzawa-Nagata, Hirofumi Misu, Seiichiro Kurita, Shuichi Kaneko, Ken-ichi Miyamoto, Satoko Nabemoto, Hiroyo Noda, Hitoshi Ando, Tsuguhito Ota, Hiroaki Takayama, Nakamura Seiji
Publikováno v:
The Journal of Biological Chemistry
Visceral adiposity in obesity causes excessive free fatty acid (FFA) flux into the liver via the portal vein and may cause fatty liver disease and hepatic insulin resistance. However, because animal models of insulin resistance induced by lipid infus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba359f4d9da5efc302132706a4f198da
http://hdl.handle.net/2297/18986
http://hdl.handle.net/2297/18986
Autor:
Tatsunobu Fukushima, Shuichi Kaneko, Hitoshi Ando, Seiichiro Kurita, Kosuke R. Shima, Naoto Matsuzawa-Nagata, Akio Fujimura, Masafumi Kumazaki, Hirofumi Misu, Toshinari Takamura, Nakamura Seiji, Naoyuki Togawa
Publikováno v:
Biochemical and Biophysical Research Communications. 380(3):684-688
金沢大学医薬保健研究域医学系
Recent studies have correlated metabolic diseases, such as metabolic syndrome and non-alcoholic fatty liver disease, with the circadian clock. However, whether such metabolic changes per se affect the c
Recent studies have correlated metabolic diseases, such as metabolic syndrome and non-alcoholic fatty liver disease, with the circadian clock. However, whether such metabolic changes per se affect the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0fb9a79629ea2673560b78a72664a57
http://hdl.handle.net/2297/17062
http://hdl.handle.net/2297/17062
Autor:
Hiroshi Akahori, Seiichiro Kurita, Hirofumi Misu, Hitoshi Ando, Yoh Zen, Tsuguhito Ota, Naoto Matsuzawa-Nagata, Shuichi Kaneko, Toshinari Takamura, Yasuni Nakanuma, Yuki Kita, Satoko Nabemoto, Masafumi Uno
Publikováno v:
Hepatology. 48:109-118
金沢大学医薬保健研究域医学系
Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease and is one of the most common liver diseases in the developed world. The histological findings of NASH are
Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease and is one of the most common liver diseases in the developed world. The histological findings of NASH are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c8073ad61be7cc8b315c7c93eb8fdf0
https://doi.org/10.1002/hep.22338
https://doi.org/10.1002/hep.22338